With a $66,714 grant from the FRAXA Research Foundation awarded over 2015-2017, Dr. Francois Corbin at the Universite of Sherbrooke will test the safety and synergistic effects of lovastatin and minocycline in patients with Fragile X syndrome.
Read moreLepage, Jean-Francois
Clinical Trial of Metformin for Fragile X Syndrome
![Clinical Trial of Metformin for Fragile X Syndrome Galarneau lab team](https://www.fraxa.org/wp-content/uploads/2019/01/DSC_3937_labo_GALARNEAU_luc-e1708720481718-720x300.jpg)
Metformin is commonly prescribed to control high blood sugar in type 2 diabetes. With a $50,000 grant from FRAXA Research Foundation, Dr. Artuela Çaku and Dr. Francois LePage are conducting an open-label clinical trial of metformin for children and adults with Fragile X syndrome, at the University of Sherbrooke in Canada.
Read more